期刊文献+

人脑胶质瘤细胞增殖指数和微血管数与病理分级的关系 被引量:3

Correlation of cell proliferation and microvessel quantity with pathologic grade in human glioma
下载PDF
导出
摘要 目的探讨人脑胶质瘤的细胞增殖指数(PI)和微血管数(MVQ)与肿瘤病理分级的关系。方法采用免疫组化方法检测50例人脑胶质瘤的增殖细胞核抗原(PCNA)及CD34的表达,计算PI和MVQ,比较PI和MVQ与脑胶质瘤病理学分级之间的关系。结果随着脑胶质瘤病理级别的升高,PI及M-vQ随之升高。Ⅰ-Ⅳ级病理分组中,除Ⅰ级与Ⅱ级间比较无差异,其余各级间比较PI和MVQ均有显著差异,且PI与MVQ呈正相关(r=O.855,P〈0.05)。结论人脑胶质瘤的细胞增殖指数和微血管数可以作为判定脑胶质细胞瘤病理级别及预后的有价值参考指标。 Objective To study the relation between cell proliferation and microvessel quantity and pathologic grade in human glioma. Methods The expression of PCNA and CD34 was detected in 50 glioma patients using immunohistochemical technology, and the proliferative index (PI) and microvessel quantity (MVQ) measured. The relation of PI and MVQ with pathologic grade of glioma was analyzed. Results The higher the pathologic grading, the higher the PI and MVQ. Except for the difference between grade :[ and grade ]I , the PI and MVQ in each pathologic grade group were signiilcanly different, and PI and MVQ were positively related ( r = O. 855, P 〈 O. 05). Conclusion PI and MVQ in glioma can be regarded as valuable markers to judge the pathologic grade and prognosis.
出处 《诊断病理学杂志》 CSCD 2009年第2期124-126,共3页 Chinese Journal of Diagnostic Pathology
  • 相关文献

参考文献4

二级参考文献43

  • 1[2]Macdonald DR. New frontiers in the treatment of malignant gliomas [J]. Semin Oncol, 2003, 30(6suppl 19): 72-76.
  • 2[3]Hentschel S J, Lang FF. Current surgical management of glioblastoma [J]. Cancer J, 2003, 9(2): 113- 125.
  • 3[4]Youmans JR. Neurological Surgery [M]. Philadelphia: WB Saunders Company, 1996:2521 - 2522.
  • 4[5]Grossman RG, Loftus CM. Primary intrinsic tumors of the brain [M]. Princinples of Neurosurgery, Second edition, Philadephia,1999, 474 - 483.
  • 5[6]Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas [J]. J Neurooncol, 1999,42(3):227-231.
  • 6[7]Davis F, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors straitified by patient age and tumor histological type: an analysis based on Surveillance,Epidemiology, and End Result (SEER) data, 1973-1991 [J]. J Neurosurgery, 1998, 88(1): 1-10.
  • 7[8]Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric and quality-of-life assessment in long-term glioblastoma survivors [J].J Neurooncol, 2003, 63 ( 1 ): 55 - 61.
  • 8[9]Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project [J]. J Neurosurg, 2003 98(6): 1175 - 1181.
  • 9[10]Botturi M, Fariselli L. Clinical results of unconventional fractionation radiotherapy in central nervous system tumors [J].Tumori, 1998, 84(2): 176 - 187.
  • 10[11]Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma[J]. Cochrane Database Syst Rev, 2002, (4):CD003913.

共引文献19

同被引文献15

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部